Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
European Urology
|
December 20, 2025
Re: Final Overall Survival and Safety Analyses of the Phase III PSMAfore Trial of [<sup>177</sup>Lu]Lu-PSMA-617 Versus Change of Androgen Receptor Pathway Inhibitor in Taxane-Naive Patients with Metastatic Castration-Resistant Prostate Cancer
Pedro C Barata, Abby L Grier
The Oncologist
|
September 27, 2025
Addressing quality-of-life challenges for patients with end-stage metastatic castrate-resistant prostate cancer
Albert Jang, Abby L Grier, Pedro C Barata
Drugs in Context
|
June 29, 2026
Perioperative immune-checkpoint inhibitors for muscle-invasive bladder cancer
Albert Jang, Abby L Grier, Iris Y Sheng, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
March 5, 2026
Balancing Cure and Quality of Life: Navigating Functional Outcomes in Localized Prostate Cancer
Abby L Grier, Erik Briers, Randie E White, et al.
Journal of Proteome Research
|
April 15, 2025
Advancing the Biochemical Understanding of Maple Syrup Urine Disease and the Impact of Liver Transplantation: A Pilot Study
Sotirios P Fortis, Abby L Grier, Julie A Reisz, et al.
The Journal of Biological Chemistry
|
May 28, 2026
Glucose-6-phosphate dehydrogenase variants modify 3D genomic organization to suppress maladaptive gene expression and vascular disease
Christina Signoretti, Shun Matsumura, Melinee D'silva, et al.
Cancers
|
February 27, 2026
Recent Advances in Immunotherapy for Non-Muscle-Invasive Bladder Cancer
Abby L Grier, Jeffrey Y Zhong, Spyridon Basourakos, et al.
Antioxidants (Basel, Switzerland)
|
August 28, 2025
Increased Exercise Tolerance in G6PD African Variant Mice Driven by Metabolic Adaptations and Erythrophagocytosis
Francesca I Cendali, Abby L Grier, Christina Lisk, et al.
Communications Medicine
|
July 27, 2025
Altered branched chain ketoacids underlie shared metabolic phenotypes in type 1 diabetes and maple syrup urine disease
Domenico Roberti, Abby L Grier, Julie A Reisz, et al.
Kidney Cancer (Clifton, Va.)
|
July 1, 2025
Durable responses to immune checkpoint inhibitor-based regimens for metastatic clear cell renal cell carcinoma stratified by IMDC risk groups: A pooled analysis of four randomized phase 3 trials
Albert Jang, Jeffrey Y Zhong, Hamsa L S Kumar, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
European Urology
|
December 20, 2025
Re: Final Overall Survival and Safety Analyses of the Phase III PSMAfore Trial of [<sup>177</sup>Lu]Lu-PSMA-617 Versus Change of Androgen Receptor Pathway Inhibitor in Taxane-Naive Patients with Metastatic Castration-Resistant Prostate Cancer
Pedro C Barata, Abby L Grier
The Oncologist
|
September 27, 2025
Addressing quality-of-life challenges for patients with end-stage metastatic castrate-resistant prostate cancer
Albert Jang, Abby L Grier, Pedro C Barata
Drugs in Context
|
June 29, 2026
Perioperative immune-checkpoint inhibitors for muscle-invasive bladder cancer
Albert Jang, Abby L Grier, Iris Y Sheng, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
March 5, 2026
Balancing Cure and Quality of Life: Navigating Functional Outcomes in Localized Prostate Cancer
Abby L Grier, Erik Briers, Randie E White, et al.
Journal of Proteome Research
|
April 15, 2025
Advancing the Biochemical Understanding of Maple Syrup Urine Disease and the Impact of Liver Transplantation: A Pilot Study
Sotirios P Fortis, Abby L Grier, Julie A Reisz, et al.
The Journal of Biological Chemistry
|
May 28, 2026
Glucose-6-phosphate dehydrogenase variants modify 3D genomic organization to suppress maladaptive gene expression and vascular disease
Christina Signoretti, Shun Matsumura, Melinee D'silva, et al.
Cancers
|
February 27, 2026
Recent Advances in Immunotherapy for Non-Muscle-Invasive Bladder Cancer
Abby L Grier, Jeffrey Y Zhong, Spyridon Basourakos, et al.
Antioxidants (Basel, Switzerland)
|
August 28, 2025
Increased Exercise Tolerance in G6PD African Variant Mice Driven by Metabolic Adaptations and Erythrophagocytosis
Francesca I Cendali, Abby L Grier, Christina Lisk, et al.
Communications Medicine
|
July 27, 2025
Altered branched chain ketoacids underlie shared metabolic phenotypes in type 1 diabetes and maple syrup urine disease
Domenico Roberti, Abby L Grier, Julie A Reisz, et al.
Kidney Cancer (Clifton, Va.)
|
July 1, 2025
Durable responses to immune checkpoint inhibitor-based regimens for metastatic clear cell renal cell carcinoma stratified by IMDC risk groups: A pooled analysis of four randomized phase 3 trials
Albert Jang, Jeffrey Y Zhong, Hamsa L S Kumar, et al.
Page
of 2